|
HS Code |
794588 |
| Name | Extractum Belladonna |
| Active Ingredient | Atropine and related alkaloids |
| Source | Atropa belladonna (Deadly Nightshade) plant |
| Form | Extract (usually liquid or semi-solid) |
| Color | Dark brown to black |
| Taste | Bitter |
| Odor | Faint, characteristic odor |
| Solubility | Soluble in alcohol, partially soluble in water |
| Pharmacological Action | Anticholinergic |
| Therapeutic Uses | Antispasmodic, pain relief adjunct |
| Route Of Administration | Oral, topical |
| Storage Conditions | Keep in a cool, dry place, protected from light |
| Toxicity | Potentially toxic; overdose can be fatal |
| Contraindications | Glaucoma, prostate enlargement, intestinal atony |
| Legal Status | Prescription only in many countries |
As an accredited Extractum Belladonna factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Extractum Belladonna packaging: Amber glass bottle, cork stopper, vintage label, 30 grams, bold black lettering, red warning border, pharmacy-use only. |
| Shipping | Extractum Belladonna should be shipped in tightly sealed, correctly labeled containers, protected from light and moisture. Transport must comply with hazardous material regulations due to its toxic nature. Ensure proper documentation accompanies the shipment, and personnel handling it must be trained in hazardous chemical safety protocols. Keep away from food and incompatible substances. |
| Storage | Extractum Belladonna should be stored in a well-closed container, protected from light and moisture to prevent degradation of its active alkaloids. Keep it in a cool, dry place, away from heat and incompatible substances. Ensure the storage area is secure and clearly labeled, as Belladonna extract is toxic and should be kept out of reach of unauthorized personnel and children. |
| Purity 98%: Extractum Belladonna with purity 98% is used in ophthalmic formulations, where it ensures rapid pupil dilation for diagnostic procedures.Alkaloid Content 0.5%: Extractum Belladonna with alkaloid content 0.5% is used in oral antispasmodic medications, where it provides effective smooth muscle relaxation.Viscosity Grade HV: Extractum Belladonna of viscosity grade HV is used in topical gels, where it guarantees optimal spreadability and sustained release.Molecular Weight 325 g/mol: Extractum Belladonna with molecular weight 325 g/mol is used in transdermal patches, where it allows controlled dermal absorption rates.Particle Size <50 µm: Extractum Belladonna with particle size less than 50 µm is used in dry powder inhalers, where it achieves uniform dispersion and rapid bioavailability.Stability Temperature 25°C: Extractum Belladonna with stability temperature 25°C is used in heat-sensitive pharmaceutical preparations, where it maintains chemical integrity during storage.Melting Point 155°C: Extractum Belladonna with melting point 155°C is used in tablet manufacturing, where it enables efficient processing without degradation.Residual Solvent <0.01%: Extractum Belladonna with residual solvent less than 0.01% is used in pediatric formulations, where it ensures safety and compliance with regulatory standards. |
Competitive Extractum Belladonna prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Extractum Belladonna has anchored itself in pharmaceutical manufacturing for decades, built on both tradition and consistent performance. Our production lines pour over every detail of this extract, from the moment the belladonna leaves arrive at our doors to the rigorous controls set in our final quality checks. Working hands-on with the raw botanical, we know what makes an extract reliable—every batch tells its own story in alkaloid content, solubility, and visual clarity.
We start with belladonna leaves harvested at peak alkaloid content, guided by years of data tracking seasonal and regional variations. Every harvest has its quirks. Leaves grown in full sun differ in strength and color from those shaded near the field edges. Tradition might treat belladonna as a uniform crop, but any manufacturer knows the terrain and weather can push the chemistry in unpredictable directions. Only a steady extraction protocol, adjusted as we learn from each batch, gives consistent scopolamine and atropine content.
We process only carefully dried leaf material, as excess moisture turns the extraction unpredictable. Our process targets key alkaloids—primarily atropine and scopolamine—without dragging along too many minor alkaloids or chlorophyll byproducts, which can complicate downstream blending. Our model focuses on a fluid extract (1:1 w/v, hydroalcoholic menstruum, standardized to 0.03%–0.05% total alkaloids). Decades in, it has become clear that balancing a strong yield with minimal secondary contaminants pays off in both batch consistency and customer safety.
Direct control over both input materials and extraction steps lets us avoid the shortcuts sometimes seen in off-the-shelf grades. We see operators reworking materials to try to “stretch” low-grade leaves, leading to variable alkaloid levels across a drum. By rejecting such practices, and sticking with incoming assay verification, our finished extract presents a reliable alkaloid profile every time. This matters in downstream tableting—for anyone who has handled belladonna in the granulation bowl, “balling” and separation from active to excipients is all too common with less refined extracts.
We avoid the “black tar syndrome”—that thick, resinous product typical of smaller-scale, solvent-pushed extracts. This trap comes from letting the leaf-to-menstruum ratio drift or rushing the evaporation. Belladonna handled at scale under GMPs gives a fluid, brownish-green solution, not a sticky solid that fouls fillers and hardens around measuring pins. Tight process controls allow our model of Extractum Belladonna to flow smoothly for exact pipetting, but still deliver the dosage strengths expected for the final dosage form.
Numbers on an assay sheet tell only half the story. As experienced manufacturers, we look beyond final titration to real-world application. Our extract delivers 0.03%–0.05% total alkaloids, usually balancing at 0.04%, with both atropine and scopolamine in pharmacopeial ratio. Color is deep brown but not tar-black, viscosity falls squarely between watery alcohol and light syrup. This soundly deposits each dose in its target container, whether into a bottle for compounding or blending into granules.
Customers using extracts for solid oral dosages value this consistency—the moment a batch jumps out of spec, blending suffers, and tablet content uniformity starts to wobble. We keep our lot-to-lot variation tight: assay, viscosity, residual solvent content, everything. Plus, those who have switched from second-tier suppliers report far fewer issues with compressed tablet finish, sticking, or crumbling due to gluey, over-processed extract.
The market sees a spread of belladonna extracts: powdered forms, soft extract, high-tar solid extract, even granules purportedly “easy to dose.” The powdered grades favor shelf-life but deliver a lower spectrum of alkaloids and are notoriously dusty. They need extra blending and often contain anti-caking agents, which interfere with some compressed solid forms. The soft or semi-solid extracts, sometimes masquerading as “concentrated liquid,” often creep up in viscosity and leave a sticky film on mixing paddles.
Our fluid extract doesn’t require added dispersants, fillers, or unlisted preservatives. It stays free-pouring down to near-freezing temperatures, so measuring never becomes a struggle on the factory floor. Compared to granulated or powdered extracts, ours offers easier blending and reduced airborne exposure risk—a very real consideration for anyone who has shoveled powder in a granulation booth and coughed through the residue.
Our experience has shown customers that switching to our Extractum Belladonna from a standard powder eliminates unpredictable sticky spots and ensures a cleaner tablet punch with each press cycle. Formulators appreciate that our extract keeps a steady chemical profile, so tablets pass internal tests time after time. This reduces in-process rework and batch waste—a benefit only visible over repeated production cycles.
Belladonna alkaloids demand respect. A slight drift in extract concentration leaves a huge impact on finished product safety—whether in CPR drops, antispasmodic tablets, or compounded tinctures. Only direct measurement at each step of production ensures each dose falls within the prescribed limits. GMP is a watchword, but true confidence only comes from running one’s own process, not relying on outside suppliers or cut-sheet compliance. We own every test and maintain constant logs for each shift on the extraction line.
Across regions, incoming regulatory requirements tighten each year: limits on minor alkaloids, heightened pesticide residue scrutiny, solvent residue limits, and a growing expectation of electronic batch recording. We have integrated electronic in-line monitoring for both solvent residues and active alkaloid content in every run. This investment was born not just out of regulatory push, but also out of too many years reviewing paper logs and asking plant chemists to guess at “borderline” results. Our philosophy: measuring is always faster than reworking.
Pharmaceutical processors often tell us stories that echo our own. Blending belladonna powder leads to dust problems, unreliable weights per tablet, and variable final alkaloid content. Liquid extracts solve some of this but introduce risks of resinous build-up or separated phases during standing. Only by controlling everything from drying time to final filtration have we matched a fluid extract to pharmaceutical blending lines, reducing residue, waste, and adjustment time.
Occasionally, we field questions from end users concerned about traditional tincture-based extracts, which remain popular in some markets. Tinctures, typically produced at lower concentrations and often lacking careful alkaloid standardization, introduce headaches for dose management and regulatory documentation. We built our Extractum model to leave behind the vagaries of old-style “tincture of belladonna” and produce a fully traceable, reliable, pharmaceutical ingredient.
Long-term customers often think of belladonna extract as a background ingredient—a utility product. Yet pharmacists, processors, and QA managers know otherwise: every failed batch, rejected lot, or adverse event due to inconsistency in this alkaloid powerhouse carries a heavy cost. With belladonna, margin for error is razor-thin. There’s no space for guesswork or substandard grade leaf sneaking through.
Consistency comes down to raw material selection, ongoing operator training, and update cycles on analytical equipment. For us, every upgrade (whether a new HPLC detector, better containment for leaf dust, or a more reliable filtration stage) translates immediately to fewer headaches for front-line users. We audit both our own collection sites and third-party analytical subcontractors, sending staff to walk the fields and see drying conditions firsthand. These measures keep us connected not just to paper specs, but to the feel and smell of the raw plant—a lesson learned from more than a few failed batches in the early years.
Resource management plays a big role in plant extract production. Organic solvents must be handled with care—recycling ethanol, minimizing residues, and controlling emissions is not a PR exercise but a basic operational need. We take pride in our in-house solvent recovery units, which have shaved costs and environmental load over years of use. By reclaiming and purifying alcohol in closed-loop systems, we not only keep costs predictable (despite swings in feedstock prices) but also meet the expected emissions footprint that comes with any serious manufacturing plant today.
Our waste stream isn’t ignored, either. Spent belladonna leaves, stripped of their major alkaloids, are composted or repurposed, never allowed to become a disposal headache. This discipline flows through the whole process: incoming material tracking, energy use monitoring, and keeping batch records clean and unambiguous. We don’t chase extraneous certifications for marketing’s sake, but respond to end-customer audits openly, providing real samples and batch logs for any investigator who walks through our doors.
Manufacturing Extractum Belladonna year after year doesn’t inspire complacency. We press for incremental upgrades: shorter extraction times without yield loss, better clarification of the final extract, and tighter solvent loss controls. Our R&D staff partner with line operators to experiment on real batches—not just bench-top models run in the lab. We found that direct talk with the production team often uncovers subtle process changes that improve the entire operation.
For instance, a recent update to our filtration step reduced process time by a full shift, freed up tank space, and cut final product particulates by half. Such results grow out of working with tools in hand, not just running numbers on a screen. Direct handling of material under real-world constraints uncovers what calculated models miss. Every time a batch succeeds or a deviation is captured early, it pays back in customer confidence and less wasteful rework.
We believe firmly in direct sourcing from known growers, which cuts out the guesswork that comes with trading desks and anonymous third-party bulk suppliers. Our procurement staff visit every farm supplying belladonna leaves. By working with growers who understand both the pharmaceutical and agricultural ends of the equation, we sidestep the quality swings that crop up in commodity trading. On the production side, this means more predictability in yield and fewer out-of-spec batches.
We have witnessed too many market disruptions from political, climate, or logistical delays to rely on intermediaries who do not share our commitment to transparency. Our agreements with suppliers include set assay guarantees and pre-defined moisture content targets. If a season’s worth of leaf doesn’t meet standard, we simply do not process it. Direct storage in our own climate-controlled facilities allows us to keep a constant buffer stock, shielding our customers from the sharp swings caused by sudden raw material shortages.
Most of our customers aren’t looking for exotic process innovations. They want a steady product without unpleasant surprises in daily production. We field calls about solving sticky mixing paddles, irregular blend dispersal, and off-spec tablet break strength. Our support team doesn’t sit in a call center—they spend time on the plant floor, retracing blending and granulation steps with actual operators. These conversations loop back into our process adjustments and inform each tech upgrade or raw material purchasing tweak.
Process engineers report fewer granulation headaches with our fluid extract than with aggressive soft extracts or powders. Production managers notice faster tank clean-outs, and pharmacists see a sharper consistency from bottle to bottle or drum to drum. The key is simple: keeping lines of feedback open with real users allows continual progress, not just theoretical improvements.
The landscape for belladonna extract is changing rapidly. Pharmaceutical producers must meet ever-stricter controls not only for alkaloid content, but also for excipient residues, solvent traces, and batch traceability. Regulatory agencies push for barcoded, real-time tracking—a welcome trend from our perspective because it rewards transparency at every level. By embedding batch coding and electronic assay data into shipping logs for every drum, we cut both paperwork errors and supply delays.
As botanical APIs gain broader scrutiny, we foresee further shifts in how both customers and inspectors approach extract quality. Direct, transparent electrochemical and chromatographic data from each batch will become the norm. We have already moved to cloud-based batch logging, which customers can access for their own compliance checks and regulatory submissions. These systems uncover errors early and keep audit trails intact, a practice that benefits both our operations and those who rely on our extracts in their finished products.
Decades of hands-on production and problem-solving have shaped our philosophy on manufacturing Extractum Belladonna. We maintain control from leaf selection through to finished extract, favoring steady results over chasing least-cost contracts or rapid expansion. This discipline cuts process headaches, reduces waste, and builds confidence among both downstream pharmaceutical formulators and final users. In the rare event of a quality issue, we investigate every step, speak plainly to our partners, and take direct action.
Above all, we listen to those who actually rely on belladonna extract to keep their plants running—production, QA, and logistics teams who have seen the “inside” of more than one batch. By combining traditional know-how with continuous process upgrades, careful sourcing, and a hands-on, straight-talking approach, we aim to keep Extractum Belladonna a product that end users can trust day after day.